483
Nancy A. Krywonis, M.D.FDA 483 - Nancy A. Krywonis, M.D. - July 23, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Nancy A. Krywonis, M.D. in Denver, CO, revealed significant deficiencies in the conduct of clinical investigations. The firm failed to adhere to investigational plans, obtain proper informed consent, ensure IRB oversight for all research sites, and maintain adequate and accurate case histories. These issues indicate a lack of compliance with regulatory requirements for clinical trials.
Open in Dashboard
ID · 8d7e2569-4dfc-4628-be99-ff8968c3a53a